In an all-hands meeting, Schwartz said she wasn’t blind to what her predecessor, Susan Monarez, went through and was clear with RFK Jr. about her approach.
Experts question technical improvements Huidagene tried when using a Duchenne muscular dystrophy treatment strategy largely abandoned by U.S. companies.